Skip to menu Skip to content Skip to footer

2019

Book Chapter

Esophageal Ulcers

Frankel, Adam J. and Smithers, B. Mark (2019). Esophageal Ulcers. Encyclopedia of Gastroenterology. (pp. 400-403) London, United Kingdom: Elsevier. doi: 10.1016/B978-0-12-801238-3.65935-4

Esophageal Ulcers

2019

Journal Article

Survival of patients with early invasive melanoma down-staged under the new 8 AJCC edition

von Schuckmann, Lena A., Hughes, Maria Celia B., Lee, Rebecca, Lorigan, Paul, Khosrotehrani, Kiarash, Smithers, B. Mark and Green, Adele C. (2019). Survival of patients with early invasive melanoma down-staged under the new 8 AJCC edition. Journal of the American Academy of Dermatology, 80 (1), 272-274. doi: 10.1016/j.jaad.2018.04.017

Survival of patients with early invasive melanoma down-staged under the new 8 AJCC edition

2019

Conference Publication

Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysis

Miura, J. T., Kroon, H. M., Beasley, G., Farrow, N. E., Mosca, P. J., Lowe, M., Farley, C., Kim, Y., Naqvi, S., Potdar, A., Daou, H., Sun, J., Mullen, D., Farma, J., Henderson, M., Serpell, J., Delman, K. A., Smithers, M., Coventry, B., Tyler, D. S., Thompson, J. and Zager, J. (2019). Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysis. 72nd Annual Cancer Symposium of the Society of Surgical Oncology (SSO), San Diego, California, 27-30 March 2019 . New York, NY, United States: Springer.

Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysis

2019

Conference Publication

Clinicopathological factors associated with death from thin (<= 1 mm) melanoma

Claeson, M., Baade, P., Brown, S., Soyer, P., Smithers, M., Green, A., Whiteman, D. and Khosrotehrani, K. (2019). Clinicopathological factors associated with death from thin (

Clinicopathological factors associated with death from thin (<= 1 mm) melanoma

2019

Conference Publication

FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapy

Trada, Y., Law, P. W., Bernard, A., Foote, M. C., Barbour, A., Lambie, D., Smithers, M., Burmeister, B. and Pinkham, M. B. (2019). FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapy. 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Chicago, Illinois, 15-18 September 2019 . Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.ijrobp.2019.06.2489

FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapy

2019

Journal Article

Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survival

Narendra, Aaditya, Baade, Peter D., Aitken, Joanne F., Fawcett, Jonathan and Smithers, Bernard Mark (2019). Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survival. HPB, 22 (9), 1288-1294. doi: 10.1016/j.hpb.2019.11.015

Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survival

2019

Book Chapter

Treatment of early oesophageal cancer

Smithers, B. Mark and Thomson, Iain (2019). Treatment of early oesophageal cancer. Oesophagogastric Surgery - A Companion to Specialist Surgical Practice. (pp. 89-99) edited by S. Michael Griffin. Edinburgh, Scotland: Elsevier.

Treatment of early oesophageal cancer

2019

Conference Publication

Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker

Chong, S., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2019). Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell.

Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker

2019

Conference Publication

Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma

Agarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan S., Shirai, Keisuke, Essner, Richard, Smithers, Bernard Mark, Atkinson, Victoria and Wachter, Eric Andrew (2019). Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il, United States, May 31-June 4, 2019. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2019.37.15_suppl.9559

Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma

2019

Journal Article

Sun protection behaviour after diagnosis of high-risk primary melanoma and risk of a subsequent primary

von Schuckmann, Lena A., Wilson, Louise F., Hughes, Maria Celia B., Beesley, Vanessa L., Janda, Monika, van der Pols, Jolieke C., Smithers, B. Mark, Khosrotehrani, Kiarash and Green, Adele C. (2019). Sun protection behaviour after diagnosis of high-risk primary melanoma and risk of a subsequent primary. Journal of the American Academy of Dermatology, 80 (1), 139-148.e4. doi: 10.1016/j.jaad.2018.06.068

Sun protection behaviour after diagnosis of high-risk primary melanoma and risk of a subsequent primary

2019

Conference Publication

IRF4 rs12203592*T/T genotype is associated with nodular melanoma

Rayner, Jenna E., McMeniman, Erin K., Duffy, David L., De'Ambrosis, Brian, Smithers, B Mark, Jagirdar, Kasturee, Lee, Katie J., Soyer, H. Peter and Sturm, Richard A. (2019). IRF4 rs12203592*T/T genotype is associated with nodular melanoma. ASDR Annual Scientific Meeting 2019, Melbourne, VIC, Australia, 16-17 May 2019.

IRF4 rs12203592*T/T genotype is associated with nodular melanoma

2018

Conference Publication

Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma

Barbour, A. P., Walpole, E. T., Mai, G. T., Barnes, L., Watson, D. I., Ackland, S. P., Wills, V., Martin, J., Burge, M., Karapetis, C. S., Shannon, J., Nott, L. M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J. R., Simes, J. and Smithers, M. (2018). Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma. 43rd ESMO Congress (ESMO), Munich Germany, Oct 19-23, 2018. OXFORD: OXFORD UNIV PRESS.

Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma

2018

Journal Article

Guidelines for perioperative care in esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations

Low, Donald E., Allum, William, De Manzoni, Giovanni, Ferri, Lorenzo, Immanuel, Arul, Kuppusamy, Madhan Kumar, Law, Simon, Lindblad, Mats, Maynard, Nick, Neal, Joseph, Pramesh, C. S., Scott, Mike, Mark Smithers, B., Addor, Valérie and Ljungqvist, Olle (2018). Guidelines for perioperative care in esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. World Journal of Surgery, 43 (2), 299-330. doi: 10.1007/s00268-018-4786-4

Guidelines for perioperative care in esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations

2018

Journal Article

Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer

Mudge, L. A., Watson, D. I., Smithers, B. M., Isenring, E. A., Smith, L., Jamieson, G. G., Australian Immunonutrition Study Group and McFarlane, Catherine (2018). Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer. The British Journal of Surgery, 105 (10), 1262-1272. doi: 10.1002/bjs.10923

Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer

2018

Journal Article

In response to: immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia

Aitken, Joanne F., Youlden, Danny R., Baade, Peter D., Soyer, H. Peter, Green, Adele C. and Smithers, B. Mark (2018). In response to: immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia. International Journal of Cancer, 143 (3), 722-723. doi: 10.1002/ijc.31347

In response to: immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia

2018

Journal Article

Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus

Effeney, R., Shaw, T., Burmeister, B. H., Burmeister, E., Harvey, J., Mai, G. T., Thomas, J., Barbour, A. P., Smithers, B. M. and Pryor, D. I. (2018). Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus. Clinical Oncology, 30 (10), 642-649. doi: 10.1016/j.clon.2018.06.011

Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus

2018

Journal Article

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Dreno, Brigitte, Thompson, John F., Smithers, Bernard Mark, Santinami, Mario, Jouary, Thomas, Gutzmer, Ralf, Levchenko, Evgeny, Rutkowski, Piotr, Grob, Jean-Jacques, Korovin, Sergii, Drucis, Kamil, Grange, Florent, Machet, Laurent, Hersey, Peter, Krajsova, Ivana, Testori, Alessandro, Conry, Robert, Guillot, Bernard, Kruit, Wim H. J., Demidov, Lev, Thompson, John A., Bondarenko, Igor, Jaroszek, Jaroslaw, Puig, Susana, Cinat, Gabriela, Hauschild, Axel, Goeman, Jelle J., van Houwelingen, Hans C., Ulloa-Montoya, Fernando ... Kirkwood, John M. (2018). MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Oncology, 19 (7), 916-929. doi: 10.1016/S1470-2045(18)30254-7

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

2018

Journal Article

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus

Visser, Els, Edholm, David, Smithers, B. Mark, Thomson, Iain G., Burmeister, Bryan H., Walpole, Euan T., Gotley, David C., Joubert, Warren L., Atkinson, Victoria, Mai, Tao, Thomas, Janine M. and Barbour, Andrew P. (2018). Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus. Journal of Surgical Oncology, 117 (8), 1687-1696. doi: 10.1002/jso.25089

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus

2018

Journal Article

Clustering of prevention behaviours in patients with high-risk primary melanoma

Green, Adèle C., Hughes, Maria Celia B., von Schuckmann, Lena A., Khosrotehrani, Kiarash and Mark Smithers, B. (2018). Clustering of prevention behaviours in patients with high-risk primary melanoma. Psycho-Oncology, 27 (5), 1442-1449. doi: 10.1002/pon.4565

Clustering of prevention behaviours in patients with high-risk primary melanoma

2018

Journal Article

Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy

Thomson, Iain G., Wallen, Matthew P., Hall, Adrian, Ferris, Rebekah, Gotley, David C., Barbour, Andrew P., Lee, Andrew, Thomas, Janine and Smithers, Bernard M. (2018). Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy. International Journal of Surgery, 53, 86-92. doi: 10.1016/j.ijsu.2018.03.030

Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy